Cancer Diagnoses Slow to Recover From Effects of COVID Pandemic Actual rates for 2021 lagged behind projections Sep 25, 2024
Omitting Biopsy After Negative MRI Halves Diagnoses of Insignificant Prostate Cancer Strategy comes with associated "low risk" of delay in diagnosis of advanced or incurable cancers Sep 25, 2024
Earlier Info on Financial Stress; Obesity and Second Cancers; Carcinogenic Condoms? News, features, and commentary about cancer-related issues Sep 19, 2024
Radionuclide-Containing Combo Slows Metastatic Prostate Cancer, Improves Survival Hazards for radiographic PFS, OS reduced by 31% with enzalutamide plus Ra-223 Sep 15, 2024
Cancer Diagnoses Still Lagging; Cancer and Family Health; New Type of Lung Cancer News, features, and commentary about cancer-related issues Sep 12, 2024
No Cellphone, Brain Cancer Link; Testosterone Paradox; Breast Density and Cancer News, features, and commentary about cancer-related issues Sep 05, 2024
Is Exercise an Effective Treatment for Prostate Cancer? A deep dive with Rob Newton, a pioneer in the field of exercise oncology Aug 28, 2024
The Global Fight Against Infection-Driven Cancers Despite vast gains in knowledge, there's still much to do if we want to save lives Aug 25, 2024
Alarm Over Pharma-China Link; Taking Screening to the People; Agriculture and Cancer News, features, and commentary about cancer-related issues Aug 23, 2024
AI Model as Effective as Radiologists in Detecting Prostate Cancer on MRI Combined findings from model and radiologists outperformed radiologists alone Aug 06, 2024
Cancer Screening Costs Over $43 Billion a Year in the U.S., Study Estimates Colorectal cancer screening accounted for 64% of the total amount Aug 05, 2024
Ancient DNA May Fuel Cancer; ASCO Appeals to Oncologists; Pesticide Cancer Risk News, features, and commentary about cancer-related issues Jul 26, 2024
Top Cancer Centers; Phase III Win in Prostate Cancer; Screening Recs for Anal Cancer News, features, and commentary about cancer-related issues Jul 19, 2024
PSMA PET Beats MRI in Prostate Cancer Staging Study Findings support PSMA PET in the preoperative workflow of intermediate- and high-risk tumors Jul 02, 2024
What's a Normal PSA Value for Transgender Women on Estrogen Therapy? Study suggests threshold is too high to identify risk of prostate cancer in this population Jun 26, 2024
AI System Beats Radiologists in Detecting Clinically Significant Prostate Cancer AI detected 6.8% more clinically significant cancers, 20% fewer indolent cancers Jun 13, 2024
Artery Inflammation and CV Events; Stepped Palliative Care for Lung Cancer Patients Also in TTHealthWatch: diets and medicine in IBS and active surveillance in prostate cancer Jun 08, 2024 podcast
Increased Heart Risks With Newer Prostate Cancer Drugs, Meta-Analysis Shows Adding ARSIs to ADT for advanced disease doubled the risk of high-grade CV events, death Jun 06, 2024
'Unusual' Cancers After Pandemic; A Win in TNBC; Shortage Pauses Clinical Trial News, features, and commentary about cancer-related issues Jun 06, 2024
Metformin Fails to Stop Early Prostate Cancer Progression Study suggests it may even be detrimental in some groups of patients on active surveillance Jun 05, 2024
Industry Clinic • Ad Insights What Will It Take to Deliver Both Health & Care in Oncology? Jun 04, 2024
Cheap Drug Eases Hot Flashes in Men With Prostate Cancer Anticholinergic oxybutynin for patients taking ADT also improved quality of life in the process Jun 03, 2024
More Evidence Backs Active Surveillance for Low-Risk Prostate Cancer Half of patients did not have grade reclassification or treatment after 10 years of follow-up May 30, 2024
Ignoring Colonoscopy Advice; Inflamed Tongue, Then Cancer; Acupuncture for Dry Mouth News, features, and commentary about cancer-related issues May 24, 2024
Psychostimulant No Help in Relieving Cancer-Related Fatigue No significant differences in outcomes between methylphenidate, placebo May 22, 2024
PSA Nadir 6 Months After Primary RT Correlates With Prostate Cancer Outcomes Or does it? Editorial questions prognostic, predictive value in contemporary practice May 22, 2024
Cancer and Intimate-Care Products; Boost for CRC Stool Tests; Biopsy by Ultrasound? News, features, and commentary about cancer-related issues May 17, 2024
Cancer Vaccines' Emergence; More Focus on Side Effects; A Nudge for Exercise News, features, and commentary about cancer-related issues May 10, 2024
Lack of Clinical Trial Availability Tied to Worse Prostate Cancer Mortality "It's a trend we really don't want to see," researcher says May 06, 2024
No PSA Recurrence at 24 Months With Apalutamide Plus ADT After Radical Prostatectomy Biochemical control maintained despite high rates of testosterone recovery May 05, 2024
HIFU Non-Inferior to Prostatectomy for Localized Prostate Cancer Better urinary and erectile function outcomes with high-intensity focused ultrasound May 04, 2024
Active Surveillance Lawsuits; More Eligibility for Studies; Biosimilars Make News News, features, and commentary about cancer-related issues May 03, 2024
Brachytherapy for Prostate Cancer Linked to Higher Risk of Second Pelvic Malignancy Risk for any second malignancy, death from any second malignancy not higher versus prostatectomy Apr 23, 2024
Salvage RT After Prostatectomy Prevails in Long-Term Comparison With Adjuvant RT No difference in freedom from distant metastasis or overall survival at 10 years Apr 19, 2024
Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests News, features, and commentary about cancer-related issues Apr 19, 2024
Urine Test Accurately Detected High-Grade Prostate Cancer Researchers say use of the test could substantially reduce unnecessary biopsies Apr 18, 2024
Could Francis Collins's Prostate Cancer Story Deter Men From Active Surveillance? Experts suggest his apparent situation is rare Apr 17, 2024
Francis Collins Discloses His 'Aggressive' Prostate Cancer Diagnosis Former NIH director said he went public to "share lifesaving information" Apr 12, 2024
Novel PARP1 Inhibitor Shows Promise in Breast Cancer The drug had favorable safety compared with first-generation PARP inhibitors in phase I/II study Apr 09, 2024
Can Late-Stage Cancer Incidence Serve as an Endpoint for Screening Trials? Study shows it may be an alternative to cancer-specific mortality for some cancers, but not all Apr 08, 2024
